These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35973847)

  • 1. Brief psychotic disorder revealing a SARS-COV-2 encephalopathy in a patient with myasthenia gravis: A case report.
    Berthet F; Niculcea DA; Younes N; Brunet-Gouet E
    Encephale; 2023 Apr; 49(2):202-204. PubMed ID: 35973847
    [No Abstract]   [Full Text] [Related]  

  • 2. New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review.
    Tereshko Y; Gigli GL; Pez S; De Pellegrin A; Valente M
    J Neurol; 2023 Feb; 270(2):601-609. PubMed ID: 36352330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
    Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
    Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis.
    Galassi G
    Neurol Sci; 2022 Oct; 43(10):5803-5804. PubMed ID: 35759066
    [No Abstract]   [Full Text] [Related]  

  • 5. Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19.
    Scopelliti G; Osio M; Arquati M; Pantoni L
    Neurol Sci; 2020 Dec; 41(12):3419-3421. PubMed ID: 33068195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneously resolving late-onset ocular myasthenia related to COVID-19. A case report.
    Popescu C
    Acta Myol; 2023; 42(2-3):89-91. PubMed ID: 38090545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
    Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
    Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myasthenia gravis associated with SARS-CoV-2 infection: a conjunction of several factors].
    Mas Maresma L; Barrachina Esteve O; Navarro Vilasaró M; Moreno-Ariño M
    Rev Esp Geriatr Gerontol; 2020; 55(6):360-361. PubMed ID: 33020016
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenia Gravis Associated With SARS-CoV-2 Infection.
    Restivo DA; Centonze D; Alesina A; Marchese-Ragona R
    Ann Intern Med; 2020 Dec; 173(12):1027-1028. PubMed ID: 32776781
    [No Abstract]   [Full Text] [Related]  

  • 10. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
    Sriwastava S; Tandon M; Kataria S; Daimee M; Sultan S
    J Neurol; 2021 Aug; 268(8):2690-2696. PubMed ID: 33047223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic health record derived-impact of COVID-19 on myasthenia gravis.
    Roy B; Kovvuru S; Nalleballe K; Onteddu SR; Nowak RJ
    J Neurol Sci; 2021 Apr; 423():117362. PubMed ID: 33639420
    [No Abstract]   [Full Text] [Related]  

  • 12. A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis.
    Chavez A; Pougnier C
    J Prim Care Community Health; 2021; 12():21501327211051933. PubMed ID: 34709075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".
    Nóbrega PR; Junior PHO; de Freitas HC; D'almeida JAC; Rodrigues CL
    Neurol Sci; 2022 Oct; 43(10):5805-5806. PubMed ID: 35941335
    [No Abstract]   [Full Text] [Related]  

  • 14. Manifestation of Ocular Myasthenia Gravis as an Initial Symptom of Coronavirus Disease 2019: A Case Report.
    Rahimian N; Alibeik N; Pishgar E; Dini P; Abolmaali M; Mirzaasgari Z
    Iran J Med Sci; 2022 Jul; 47(4):385-388. PubMed ID: 35919075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?
    Rzepiński Ł; Wawrzyniak S; Maciejek Z
    Neurol Neurochir Pol; 2020; 54(5):481-482. PubMed ID: 33006133
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and Immunogenicity of Additional SARS-CoV-2 Vaccinations in a Patient With Myasthenia Gravis on Mycophenolate: A Case Report.
    McNeish BL; Colletti RB; Hehir MK
    J Clin Neuromuscul Dis; 2022 Dec; 24(2):113-114. PubMed ID: 36409346
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
    Ramaswamy SB; Govindarajan R
    J Neuromuscul Dis; 2020; 7(3):361-364. PubMed ID: 32508329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection.
    Chen Y; Wan W; Yao X; Guan Y
    J Neuroimmunol; 2023 Dec; 385():578245. PubMed ID: 37992586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on COVID-19 in patients with myasthenia gravis.
    Galassi G; Marchioni A
    Muscle Nerve; 2020 Dec; 62(6):E85-E86. PubMed ID: 32929765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.